1Lazar HL, Bao Y, Rivers S, et al. Pretreatment with angiotensin converting enzyme inhibitors attenuates ischemia - reperfusion injury[J]. Ann Thorac Surg, 2003, 73(5): 152-155.
2Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin - convetting- enzyme inhibitor, ramipril, on cardiovascular events in high- risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med 2005, 342 (3): 145 - 153.
3Chung B. Increased left ventricular mass after Losartan treatment[J]. Lancet, 1997, 349: 1743-1744.
5Linz W, Wiemer G, Scholkens BA. Role of kinins in the pathophysiology of myocardial ischemia: in vitro and in vivo studies[J].Diabetes, 2004, 45 (Suppll): S51.
6Bary M. Brenner, et al. Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J]. New Eng J Med, 2005, 345:861.
9Culman J, von Heyer C, Piepenbury B , et al. Effects of systemic treatment with irbesartan and Losartan on central responses to angiotensin Ⅱ in conscious , normot- ensive rats[J]. EurJ Pharmacol , 2004, 367: 255 - 265.
7Packer M, Bristow M R, Cohn J N, et al. For the US carvedilol heart failure study group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med, 1996,334(21) : 1349 -1355.
8MERIT-HF study group. Effect of metroprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J]. Lancet, 1999,353(9196):2001-2007.
9Kim Y K, Kim S J, Kramer C M, et al. Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial inffarction[J]. J Mol Cell Cattdial, 2002,34(1):63-73.
10Hasegawa K, Iwai-Kanai E, Sasayama S. Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure[J]. J CellPhysiol, 2001,186( 1 ) : 11 - 18.
